REPOSICAO HIDROELETROLITICA E ALIMENTACAO PARENTERAL - Rezultatele cautarii

Uniunea Europeană - română - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod clorhidrat de - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresoare - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zeposia 0,23 mg/0,46 mg

celgene distribution b.v. - olanda - ozanimodum - caps. - 0,23mg+0,46mg - imunosupresoare imunosupresoare selective

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zeposia 0,92 mg

celgene distribution b.v. - olanda - ozanimodum - caps. - 0,92mg - imunosupresoare imunosupresoare selective

Uniunea Europeană - română - EMA (European Medicines Agency)

imvanex

bavarian nordic a/s - vaccinia modificată ankara - virusul nordic bavarez (mva-bn) - smallpox vaccine; monkeypox virus - alte vaccinuri virale, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 și 5. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.